Retention and biodistribution of microspheres injected into ischemic myocardium
- 11 March 2008
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 88A (3), 704-710
- https://doi.org/10.1002/jbm.a.31917
Abstract
Intramyocardial injection of therapeutic agents may enhance heart repair after infarction. Incomplete retention of intramyocardial injections has been reported, but modes of loss are undefined. We determined the fate of neutron-activated microspheres injected into acutely ischemic rat myocardium using saline, Pluronic F127, or Matrigel as vehicle. Twenty minutes after injection in saline, 63% ± 12% of 10-μm microspheres was retained in the heart. Similar retention was observed after 6 days. Injection site leakage accounted for 14% ± 5% of the microspheres, whereas exit via coronary veins resulted in 11.2% ± 9.5% collecting in the lungs. Microspheres distribution to other organs was minimal. Retention of 40-μm microspheres was similar to that observed with the 10-μm microspheres. Pluronic F127 and Matrigel reduced immediate leakage to 4% ± 1% and 2% ± 1%, respectively. Surprisingly, microsphere retention in the heart was not improved at 20 min using either gelling vehicle, suggesting that leakage occurs over a prolonged period. Thus, most injected particles are retained in the ischemic rat heart following direct injection, but significant fractions are lost from the injection site and through coronary veins. Gelling agents reduced short-term leakage, but failed to enhance longer-term retention. Hydrogels with stiffer mechanical properties might enhance retention and reduce variability. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009Keywords
This publication has 22 references indexed in Scilit:
- Wound dressings containing bFGF-impregnated microspheresJournal of Microencapsulation, 2006
- Washout of transplanted cells from the heart: A potential new hurdle for cell transplantation therapyCardiovascular Research, 2005
- Regenerating the heartNature Biotechnology, 2005
- TRANSENDOCARDIAL AND TRANSEPICARDIAL INTRAMYOCARDIAL FIBROBLAST GROWTH FACTOR-2 ADMINISTRATION: MYOCARDIAL AND TISSUE DISTRIBUTIONDrug Metabolism and Disposition, 2005
- Growth factor-induced therapeutic angiogenesis in the heart: protein therapyCardiovascular Research, 2005
- Microspheres for controlled release drug deliveryExpert Opinion on Biological Therapy, 2004
- Enhancing the vascularization of three‐dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheresJournal of Biomedical Materials Research Part A, 2003
- Exploring Heart Lymphatics in Local Drug DeliveryLymphatic Research and Biology, 2003
- Survival and Development of Neonatal Rat Cardiomyocytes Transplanted into Adult MyocardiumJournal of Molecular and Cellular Cardiology, 2002
- EGF containing gelatin-based wound dressingsBiomaterials, 2001